Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations.

Ringman JM, Fithian AT, Gylys K, Cummings JL, Coppola G, Elashoff D, Pratico D, Moskovitz J, Bitan G.

Dement Geriatr Cogn Disord. 2012;33(4):219-25. doi: 10.1159/000338546. Epub 2012 May 14.

PMID:
22584618
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Biochemical markers in persons with preclinical familial Alzheimer disease.

Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL.

Neurology. 2008 Jul 8;71(2):85-92. doi: 10.1212/01.wnl.0000303973.71803.81. Epub 2008 May 28.

PMID:
18509095
[PubMed - indexed for MEDLINE]
3.

Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

Ringman JM, Elashoff D, Geschwind DH, Welsh BT, Gylys KH, Lee C, Cummings JL, Cole GM.

Arch Neurol. 2012 Jun;69(6):757-64. doi: 10.1001/archneurol.2012.277.

PMID:
22689192
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Increased prevalence of significant recurrent headache in preclinical familial Alzheimer's disease mutation carriers.

Ringman JM, Romano JD, Medina LD, Rodriguez-Agudelo Y, Schaffer B, Varpetian A, Ortiz F, Fitten LJ, Cummings JL, Baloh RW.

Dement Geriatr Cogn Disord. 2008;25(4):380-4. doi: 10.1159/000121986. Epub 2008 Mar 29.

PMID:
18376127
[PubMed - indexed for MEDLINE]
5.

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.

Ringman JM, Schulman H, Becker C, Jones T, Bai Y, Immermann F, Cole G, Sokolow S, Gylys K, Geschwind DH, Cummings JL, Wan HI.

Arch Neurol. 2012 Jan;69(1):96-104. doi: 10.1001/archneurol.2011.642.

PMID:
22232349
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.

Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Gilbert PE, Liang LJ, Cummings JL, Ringman JM.

Dement Geriatr Cogn Disord. 2011;32(3):188-92. doi: 10.1159/000333023. Epub 2011 Aug 30.

PMID:
22134129
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S.

Nat Med. 1996 Aug;2(8):864-70.

PMID:
8705854
[PubMed - indexed for MEDLINE]
8.

Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway.

Marques CA, Keil U, Bonert A, Steiner B, Haass C, Muller WE, Eckert A.

J Biol Chem. 2003 Jul 25;278(30):28294-302. Epub 2003 May 1.

PMID:
12730216
[PubMed - indexed for MEDLINE]
Free Article
9.

Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.

De Jonghe C, Cras P, Vanderstichele H, Cruts M, Vanderhoeven I, Smouts I, Vanmechelen E, Martin JJ, Hendriks L, Van Broeckhoven C.

Neurobiol Dis. 1999 Aug;6(4):280-7.

PMID:
10448055
[PubMed - indexed for MEDLINE]
10.

Detection of oxidized methionine in selected proteins, cellular extracts and blood serums by novel anti-methionine sulfoxide antibodies.

Oien DB, Canello T, Gabizon R, Gasset M, Lundquist BL, Burns JM, Moskovitz J.

Arch Biochem Biophys. 2009 May 1;485(1):35-40.

PMID:
19388147
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Familial Alzheimer's disease genes in Japanese.

Kamimura K, Tanahashi H, Yamanaka H, Takahashi K, Asada T, Tabira T.

J Neurol Sci. 1998 Sep 18;160(1):76-81.

PMID:
9804121
[PubMed - indexed for MEDLINE]
13.

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.

Pera M, Alcolea D, Sánchez-Valle R, Guardia-Laguarta C, Colom-Cadena M, Badiola N, Suárez-Calvet M, Lladó A, Barrera-Ocampo AA, Sepulveda-Falla D, Blesa R, Molinuevo JL, Clarimón J, Ferrer I, Gelpi E, Lleó A.

Acta Neuropathol. 2013 Feb;125(2):201-13. doi: 10.1007/s00401-012-1062-9. Epub 2012 Dec 6.

PMID:
23224319
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.

Lleó A, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Peña-Casanova J, Rojo A, Oliva R.

Arch Neurol. 2002 Nov;59(11):1759-63.

PMID:
12433263
[PubMed - indexed for MEDLINE]
15.

Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.

Hahn S, Brüning T, Ness J, Czirr E, Baches S, Gijsen H, Korth C, Pietrzik CU, Bulic B, Weggen S.

J Neurochem. 2011 Feb;116(3):385-95. doi: 10.1111/j.1471-4159.2010.07118.x. Epub 2010 Dec 13.

PMID:
21091478
[PubMed - indexed for MEDLINE]
16.

Genetic study of Sardinian patients with Alzheimer's disease.

Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R, Deiana E, Piras MR, Confaloni A.

Neurosci Lett. 2006 May 1;398(1-2):124-8. Epub 2006 Jan 19.

PMID:
16423463
[PubMed - indexed for MEDLINE]
17.

Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer's disease.

Ringman JM, Pope W, Salamon N.

J Neurol. 2010 May;257(5):839-42. doi: 10.1007/s00415-009-5436-4. Epub 2010 Jan 3.

PMID:
20047059
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.

Ishii K, Lippa C, Tomiyama T, Miyatake F, Ozawa K, Tamaoka A, Hasegawa T, Fraser PE, Shoji S, Nee LE, Pollen DA, St George-Hyslop PH, Ii K, Ohtake T, Kalaria RN, Rossor MN, Lantos PL, Cairns NJ, Farrer LA, Mori H.

Neurobiol Aging. 2001 May-Jun;22(3):367-76.

PMID:
11378241
[PubMed - indexed for MEDLINE]
19.

Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.

Wiley JC, Hudson M, Kanning KC, Schecterson LC, Bothwell M.

J Neurochem. 2005 Sep;94(5):1189-201. Epub 2005 Jun 30.

PMID:
15992373
[PubMed - indexed for MEDLINE]
20.

The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex.

Bogdanovic N, Zilmer M, Zilmer K, Rehema A, Karelson E.

Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):364-70.

PMID:
11598307
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk